Corporate Banner
Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Tumor-suppressor Protein Gives Up Its Secrets

Published: Friday, July 12, 2013
Last Updated: Friday, July 12, 2013
Bookmark and Share
Discovery promises new targets for cancer drug design.

Genetic mutations aren’t the only thing that can keep a protein called PTEN from doing its tumor-suppressing job. Johns Hopkins researchers have now discovered that four small chemical tags attached (reversibly) to the protein’s tail can have the same effect, and they say their finding may offer a novel path for drug design to keep PTEN working.

In a report published on July 9 in the journal eLife, the Johns Hopkins scientists describe how a cluster of four phosphate groups, first found 13 years ago to bind to PTEN’s tail, controls its activity.

“Now that we know how these phosphate tags are involved in regulating PTEN’s activity, new options may be available for drugs that interfere with them,” says Philip A. Cole, M.D., Ph.D., the E.K. Marshall and Thomas H. Maren Professor and director of the Department of Pharmacology and Molecular Sciences at the Johns Hopkins University School of Medicine.

In addition to phosphate tags, mutations in genes that code for a protein can cause some protein activities to be permanently on or off. Mutations that deactivate PTEN often lead to cancer because PTEN’s job is to prevent cells from dividing too much, Cole notes. But there are times when a cell needs to divide to replace dead cells, so scientists knew there had to be a naturally occurring mechanism for turning PTEN off, and they hypothesized that the phosphates on its tail were responsible, as they are in other proteins.

To get at the heart of the question, the Johns Hopkins team had to overcome technical obstacles, including a way to engineer a special version of PTEN in which the phosphates were permanently bound to the tail.

“We had to synthesize the tail of PTEN in the lab and then fit that together with the rest of PTEN, which was made by insect cells,” says David Bolduc, a graduate student in Cole’s laboratory and the lead author of the paper. “Once we cleared that hurdle, we were able to learn a lot more about how phosphates regulate PTEN.”

Armed with their engineered protein, the team analyzed its shape, where in cells it was located and its activity — tasks aided by miniature X-ray imagers and biochemical tests that shed light on how PTEN interacted with other entities, like PIP3, a fat-like molecule located just inside the outer envelope of cells.

The team found that when there are no phosphates on PTEN’s tail, it is in its active form and it removes a phosphate tag from PIP3. The loss of the phosphate alters PIP3’s activity and causes a chain reaction of effects on other important regulatory proteins that ultimately suppresses cell division and migration, both deadly aspects of tumor progression.

Cole explains that when a cell needs to divide, another protein, most often CK2, adds phosphates to PTEN’s tail, causing a change in its shape and location. Its tail curls back on the rest of the protein and prevents it from interacting with PIP3 in the outer envelope of the cell, so PTEN ends up inactive, in the fluid-filled middle of the cell. When the phosphates are removed, PTEN relocates to the outer envelope, where it removes a phosphate tag from PIP3 to initiate the chain reaction that suppresses tumor formation.

“The tail of PTEN actually has a competition going on between binding to itself and binding to the outer envelope of the cell where PIP3 is located,” explains Bolduc. “Any drug that can prevent the tail from binding itself might also maintain the tumor-fighting activity of PTEN.”

According to Cole, many cancer patients have an overabundance of CK2, the protein that adds phosphates to PTEN and turns it off. So, increasing the activity of PTEN might be helpful not only to patients with defective PTEN, but also to those with cancer-causing mutations in other proteins.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,400+ scientific posters on ePosters
  • More than 4,900+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Paternal Sperm May Hold Clues to Autism
Tags on DNA from fathers’ sperm linked to children’s autism symptoms.
Friday, April 17, 2015
New Autism-Causing Genetic Variant Identified
Novel approach expected to be useful for other diseases too.
Saturday, March 28, 2015
Bad Luck of Random Mutations Plays Predominant Role in Cancer, Study Shows
Statistical modeling links cancer risk with number of stem cell divisions.
Tuesday, January 06, 2015
Cancer Leaves a Common Fingerprint on DNA
Chemical alterations to genes appear key to tumor development.
Tuesday, August 26, 2014
Signals Found That Recruit Host Animals’ Cells, Enabling Breast Cancer Metastasis
Mouse studies suggest that blocking aid from white blood cells and stem cells could keep tumors contained.
Thursday, May 22, 2014
Common Genetic Pathway Could Be Conduit to Pediatric Tumor Treatment
Investigators have found a known genetic pathway to be active in many difficult-to-treat pediatric brain tumors called low-grade gliomas.
Monday, November 11, 2013
A Simple Blood Test May Catch Early Pancreatic Cancer
Currently, disease usually found too late to save lives.
Wednesday, October 30, 2013
Discovery Increases Diagnostic Certainty and Opportunity for Individualized Drug Therapy
Of the over 1,900 errors already reported in the gene responsible for CF, it is unclear how many of them actually contribute to the inherited disease.
Thursday, August 29, 2013
Cancer-Linked Fam190a Gene Found to Regulate Cell Division
A little-described gene known as FAM190A plays a subtle but critical role in regulating the normal cell division process known as mitosis.
Monday, July 08, 2013
Cancer-Linked Fam190a Gene Found to Regulate Cell Division
Scientists have discovered that a little-described gene known as FAM190A plays a subtle but critical role in regulating the normal cell division process known as mitosis.
Thursday, July 04, 2013
Family Studies Suggest Rare Genetic Mutations Team Up To Cause Schizophrenia
Genome-wide analysis suggests “no single genetic recipe” for the mental disorder.
Thursday, May 30, 2013
Genetic Variation Doubles Risk of Aortic Valve Calcification
Study is the first to show cause-and-effect relationship between a gene variant and calcium deposits on the aortic valve.
Monday, February 18, 2013
Rare Form of Active 'Jumping Genes' Found In Mammals
Johns Hopkins researchers report they have identified a new DNA sequence moving around in bats.
Wednesday, January 09, 2013
Scientists Pair Blood Test and Gene Sequencing to Detect Cancer
Scientists have combined the ability to detect cancer DNA in the blood with genome sequencing technology in a test that could be used to screen for cancers, monitor cancer patients for recurrence and find residual cancer left after surgery.
Friday, November 30, 2012
Researchers Link New Molecular Culprit to Breast Cancer Progression
Johns Hopkins researchers have uncovered a protein “partner” commonly used by breast cancer cells to unlock genes needed for spreading the disease around the body.
Wednesday, November 28, 2012
Scientific News
Probing How CRISPR-Cas9 Works
New study in Journal of Cell Biology examines DNA targeting dynamics in live cells.
Diagnosing Tumors of Unknown Origin
EPICUP® test is a tool that helps to identify up to 87% of cancers of unknown origin (COD).
Genome Editing Without Cleaving DNA
A team involving Kobe University researchers has succeeded in developing ‘Target-AID’, a genome editing technique that does not cleave the DNA.
New Possibilities Tumor Research
Grazer researchers say gene activity of the tumor from the analysis of circulating DNA in blood ahead.
Controlling Genome Editing with Light
New technique offers precise manipulation of when and where genes are targeted.
Breast Cancer Cells Found To Switch Molecular Characteristics
Spontaneous interconversion between HER2-positive and HER2-negative states could contribute to progression, treatment resistance in breast cancer.
Some Breast Cancer Patients With Low Genetic Risk Could Skip Chemotherapy
Genetic test can help predict survival and guide treatment options.
Lose Weight, Escape the Eight: Weight-Based Cancer Risk
IARC has identified eight additional cancer sites linked to overweight and obesity.
Coffee Consumption Linked to Genes
Researchers have identified a gene that influences coffee consumption. The gene is thought to relate to caffeine breakdown.
Emerging Model of Cancer
Cancer acts cooperatively, making individual decisions but acting in unison; this insight is being used to create a computer model of cancer.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!